Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TSX/XLY stock hub

TSX/XLY has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TSX/XLYis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
200.5M
Toronto Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TSX/XLY
In the news

Latest news · TSX/XLY

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11.8
P25 11P50 15.6P75 25.4
Trailing P/E4.7
P25 7.4P50 15.6P75 34.3
ROE28.5
P25 -121.5P50 -40.9P75 0.5
ROIC15.9
P25 -72.5P50 -16P75 1.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TSX/XLY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
207
Groups with data
11
Currency
CAD
Showing 207 of 207 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Canada
Country code
CA
Employees
446
Employees Change
58%
Employees Change Percent
14.95
Enterprise value
CAD 225.8M
Exchange
Toronto Stock Exchange
Financial currency
CAD
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
CA05335P1099
Last refreshed
2026-05-10
Market cap
CAD 200.5M
Price
CAD 0.14
Price currency
CAD
Rev Per Employee
339,645.74x
Sector
Healthcare
Sic
6211
Symbol
tsx/XLY
Website
https://www.auxly.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

11
MetricValue
Earnings Yield
20.87%
EV Earnings
5.39x
EV/EBIT
6.91x
EV/EBITDA
5.12x
EV/FCF
9.53x
EV/Sales
1.49x
FCF yield
11.81%
Forward P/E
11.78x
P/B ratio
1.13x
P/E ratio
4.67x
P/S ratio
1.32x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

23
MetricValue
EBIT Margin
21.57%
EBITDA Margin
28.31%
FCF margin
15.63%
Gross margin
57.26%
Gross Profit
CAD 86.7M
Gross Profit Growth
44.74%
Gross Profit Growth Q
-1.06%
Gross Profit Growth3 Y
73.84%
Gross Profit Growth5 Y
54.63%
Net Income
CAD 41.9M
Net Income Growth Q
-78.68%
Net Income Growth Years
3%
Pretax Margin
21.47%
Profit Margin
27.63%
Profit Per Employee
CAD 93,845
Profitable Years
1
ROA
7.66
Roa5y
-1.6
ROCE
14.42
ROE
28.55
Roe5y
-33.57
ROIC
15.91
Roic5y
-2.41

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

17
MetricValue
Cagr10y
21.49%
Cagr1y
64.76%
Cagr3y
110.51%
Cagr5y
-17.67%
EPS Growth Q
-91.75
EPS Growth Years
3
FCF Growth
68.95%
FCF Growth Q
317.51%
OCF Growth
56.12%
OCF Growth Q
236.63%
OCF Growth10 Y
95.21%
Revenue Growth
23.83x
Revenue Growth Q
15.85x
Revenue Growth Quarters
10x
Revenue Growth Years
7x
Revenue Growth3 Y
17.04x
Revenue Growth5 Y
26.52x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
CAD 0.57
Assets
CAD 271.6M
Cash
CAD 32.4M
Current Assets
CAD 99.2M
Current Liabilities
CAD 45.1M
Debt
CAD 57.6M
Debt EBITDA
CAD 1.31
Debt Equity
CAD 0.32
Debt FCF
CAD 2.43
Equity
CAD 177.6M
Interest Coverage
4.91
Liabilities
CAD 94.1M
Long Term Assets
CAD 172.4M
Long Term Liabilities
CAD 48.9M
Net Cash
CAD -25.2M
Net Cash By Market Cap
CAD -12.58
Net Debt EBITDA
CAD 0.59
Net Debt Equity
CAD 0.14
Net Debt FCF
CAD 1.07
Tangible Book Value
CAD 149.4M
Tangible Book Value Per Share
CAD 0.11
WACC
10.18

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
2.2
Inventory Turnover
1.68
Net Working Capital
CAD 30.4M
Quick ratio
1.21
Working Capital
CAD 54.1M
Working Capital Turnover
CAD 40.83

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-31.72%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
10Y total return
600%
1Y total return
64.71%
200-day SMA
0.14
3Y total return
833.33%
50-day SMA
0.13
50-day SMA vs 200-day SMA
50under200
5Y total return
-62.16%
All Time High
2.97
All Time High Change
-95.29%
All Time High Date
2018-01-04
All Time Low
0
All Time Low Change
8,135.29%
All Time Low Date
2013-03-15
ATR
0.01
Beta
1.13
Beta1y
0.43
Beta2y
1.08
Ch YTD
-3.45
High
0.14
High52
0.19
High52 Date
2025-11-12
High52ch
-26.32%
Low
0.14
Low52
0.08
Low52 Date
2025-06-13
Low52ch
86.67%
Ma50ch
6.46%
Price vs 200-day SMA
-1.13%
RSI
53.26
RSI Monthly
60.7
RSI Weekly
53.24
Sharpe ratio
0.97x
Sortino ratio
1.74
Total Return
-31.72%
Tr YTD
-3.45
Tr1m
12%
Tr3m
7.69%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

4
MetricValue
Operating Income
CAD 32.7M
Operating Income Growth
122
Operating Income Growth Q
-59.14
Operating margin
21.57

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
1,110,728,412%
Net Borrowing
-10,562,000
Shares Insiders
5.17%
Shares Institutions
0.01%
Shares Out
1,432,403,425
Shares Qo Q
1.72%
Shares Yo Y
31.72%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

59
MetricValue
Adjusted FCF
CAD 18.4M
Average Volume
599,848.1x
Bv Per Share
0.13
CAPEX
CAD -2.5M
Ch10y
600
Ch1m
12
Ch1y
64.71
Ch3m
7.69
Ch3y
833.3
Ch5y
-62.16
Ch6m
-9.68
Change
3.7%
Change From Open
3.7
Close
0.14
Days Gap
0
Depreciation Amortization
10,211,000
Dollar Volume
27,120
Earnings Date
2026-05-14
EBIT
CAD 32.7M
EBITDA
CAD 42.9M
EPS
CAD 0.03
F Score
6
FCF
CAD 23.7M
FCF EV Yield
10.49x
FCF Per Share
CAD 0.02
Financing CF
-9,809,000
Fiscal Year End
December
Founded
1,987
Graham Number
0.29611
Graham Upside
111.5
Income Tax
CAD -9.3M
Investing CF
-2,462,000
Is Primary Listing
1
Last Earnings Date
2025-11-07
Last Report Date
2025-12-31
Last Split Date
2017-04-10
Last Split Type
Forward
Ma150
0.14
Ma150ch
0.43%
Ma20
0.14
Ma20ch
1.6%
Net CF
13,923,000
Next Earnings Date
2026-05-14
Open
0.14
P FCF Ratio
8.47
P OCF Ratio
7.66
Position In Range
100
Ppne
143,636,000
Price Date
2026-05-08
Price EBITDA
CAD 4.68
Ptbv Ratio
1.34
Relative Volume
0.32x
Revenue
151,482,000x
SBC By Revenue
3.48x
Share Based Comp
5,265,000
Tax By Revenue
-6.16x
Tr6m
-9.68%
Volume
193,714
Z Score
-0.22
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does TSX/XLY pay a dividend?

Capital-return profile for this ticker.

Performance

TSX/XLY stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+64.7%
S&P 500 1Y: n/a
3Y total return
+833.3%
S&P 500 3Y: n/a
5Y total return
-62.2%
S&P 500 5Y: n/a
10Y total return
+600.0%
S&P 500 10Y: n/a
Ownership

Who owns TSX/XLY?

Insider, institutional, and short-interest positioning.

Institutional ownership
+0.0%
Share of float held by funds and institutions
Insider ownership
+5.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+31.7%
Negative means the company is buying back shares.
Technical

TSX/XLY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
53.3
Neutral momentum band
Price vs 200-day MA
-1.1%
50/200-day relationship not available
Beta (5Y)
1.13
Moves roughly with the market
Sharpe ratio
0.97
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TSX/XLY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsx/XLY stock rating?

tsx/XLY is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsx/XLY analysis?

The full report lives at /stocks/tsx/XLY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsx/XLY?

The latest report frames tsx/XLY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsx/XLY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.